Theme · live manifest · live theme JSON
GLP-1 Short '24: Health Insurance
3 tickers · $423.05B total market cap
Group: GLP-1 Short
The thesis regarding GLP-1 drugs and their impact on health insurance is mixed as of Spring 2025. The widespread adoption of GLP-1 drugs may lead to reduced long-term healthcare costs due to improved overall health outcomes, potentially benefiting insurers. However, the initial costs associated with covering these expensive medications could pressure insurers' short-term profitability. Additionally, the uncertain regulatory environment regarding drug coverage and pricing presents both risks and opportunities for insurers.
GLP-1 Short '24: Health Insurance tracks 3 publicly listed stocks in this theme: AON, EVH, UNH. See the constituent table for details.
Thesis update: 2025-04-01
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
UnitedHealth Group IncorporatedUNH | 04/21/2026 (BMO) | 04/21/2026 (BMO) | -16.39% | 9.29% | 10.02% | 10.10% | $353.49B | 33.3333 |
Aon plcAON | 05/01/2026 (BMO) | 05/01/2026 (BMO) | 1.95% | 0.22% | -10.91% | 3.90% | $69.13B | 33.3333 |
Evolent Health, Inc.EVH | 05/07/2026 (AMC) | 05/07/2026 (AMC) | 29.69% | 9.14% | 28.61% | -6.94% | $437.6M | 33.3333 |
| Average | 5.08% | 6.21% | 9.24% | 2.36% | $141.02B | 33.3333 | ||
| Median | 1.95% | 9.14% | 10.02% | 3.90% | $69.13B | 33.3333 | ||
| Std Dev | 18.94% | 4.24% | 16.15% | 7.04% | $152.83B | 0.0% | ||
| Min | -16.39% | 0.22% | -10.91% | -6.94% | $437.6M | 33.3333 | ||
| Max | 29.69% | 9.29% | 28.61% | 10.10% | $353.49B | 33.3333 | ||
| % Positive Tickers | 66.67% | 100.00% | 66.67% | 66.67% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.